<i>In Vitro</i> and <i>In Vivo</i> Efficacy of NITD-916 against Mycobacterium fortuitum-Reference-Cited by-同舟云学术

In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum

Published:2023-04-18 Issue:4 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Roquet-Banères Françoise¹,Alcaraz Matthéo¹,Hamela Claire¹,Abendroth Jan²³,Edwards Thomas E.²³,Kremer Laurent¹⁴^ORCID

Affiliation:

1. Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France

2. UCB BioSciences, Bainbridge Island, Washington, USA

3. Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA

4. INSERM, IRIM, Montpellier, France

Abstract

Mycobacterium fortuitum represents one of the most clinically relevant rapid-growing mycobacterial species. Treatments are complex due to antibiotic resistance and to severe side effects of effective drugs, prolonged time of treatment, and co-infection with other pathogens.

Funder

HHS | National Institutes of Health

National Research Agency

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01607-22

Reference55 articles.

1. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus

2. Trends and Species Diversity of Non-tuberculous Mycobacteria Isolated From Respiratory Samples in Northern China, 2014–2021